These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Case report: symptomatic oral herpes simplex virus type 2 and asymptomatic genital shedding. Olin L; Wald A Herpes; 2006 May; 13(1):25-6. PubMed ID: 16733000 [TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Baker D; Brown Z; Hollier LM; Wendel GD; Hulme L; Griffiths DA; Mauskopf J Am J Obstet Gynecol; 2004 Dec; 191(6):2074-84. PubMed ID: 15592294 [TBL] [Abstract][Full Text] [Related]
44. Genital herpes: a review. Beauman JG Am Fam Physician; 2005 Oct; 72(8):1527-34. PubMed ID: 16273819 [TBL] [Abstract][Full Text] [Related]
45. Health related quality of life in genital herpes: a pilot comparison of measures. Fisman DN Sex Transm Infect; 2005 Jun; 81(3):267-70. PubMed ID: 15923300 [TBL] [Abstract][Full Text] [Related]
47. Herpes simplex virus in pregnancy: new concepts in prevention and management. Hill J; Roberts S Clin Perinatol; 2005 Sep; 32(3):657-70. PubMed ID: 16085025 [TBL] [Abstract][Full Text] [Related]
48. An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2). Rose WA; Tuthill C; Pyles RB Int J Antimicrob Agents; 2008 Sep; 32(3):262-6. PubMed ID: 18619817 [TBL] [Abstract][Full Text] [Related]
49. Audit of the management of genital herpes simplex infection. Matin RN; Brady M; Poulton M Int J STD AIDS; 2006 Dec; 17(12):851-3. PubMed ID: 17212865 [TBL] [Abstract][Full Text] [Related]
50. Time to translate new knowledge into practice: a call for a national genital herpes control program. Hook EW; Leone P J Infect Dis; 2006 Jul; 194(1):6-7. PubMed ID: 16741875 [No Abstract] [Full Text] [Related]
52. Antiviral therapy for genital herpes infections in pregnancy. Baker DA Expert Rev Anti Infect Ther; 2005 Jun; 3(3):385-92. PubMed ID: 15954855 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of 2LHERP in preventing recurrences of genital herpes. Institut International 3IDI. Jenaer M; Henry MF; Garcia A; Marichal B Br Homeopath J; 2000 Oct; 89(4):174-7. PubMed ID: 11055774 [TBL] [Abstract][Full Text] [Related]
54. Reluctance to prescribe suppressive oral acyclovir for recurrent genital herpes. Mindel A Lancet; 1990 May; 335(8697):1107. PubMed ID: 1970414 [No Abstract] [Full Text] [Related]
55. Health-related quality of life of young people and adults with primary or recurrent episodes of genital herpes: a mixed methods systematic review protocol. Bennett C; Rebafka A; Carrier J; Edwards D; Jones J JBI Database System Rev Implement Rep; 2018 May; 16(5):1087-1094. PubMed ID: 29762300 [TBL] [Abstract][Full Text] [Related]
56. [Psychological reactions of patients with recurrent genital herpes]. Odegaard BS; Laerum E Tidsskr Nor Laegeforen; 1986 Sep; 106(27):2253-5. PubMed ID: 3787583 [No Abstract] [Full Text] [Related]
57. Antiviral therapies for long-term suppression of genital herpes. Jefferson JW JAMA; 1999 Apr; 281(13):1170-1. PubMed ID: 10199420 [No Abstract] [Full Text] [Related]
59. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus. Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045 [TBL] [Abstract][Full Text] [Related]
60. What you need to know about genital herpes. Snow M Nursing; 2011 Jul; 41(7):58. PubMed ID: 21670657 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]